Article
Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial.
Bone marrow transplantation - 1 Mar 2014
Wang Y, Fu H-X, Liu D-H, Xu L-P, Zhang X-H, Chang Y-J, Chen Y-H, Wang F-R, Sun Y-Q, Tang F-F, Liu K-Y, Huang X-J
Abstract excerpt
To evaluate the effect of the different doses of antithymocyte globulin (ATG) on the incidence of acute GVHD among patients receiving hematopoietic SCT without ex vivo T-cell-depletion from haploidentical donors, 224 patients with standard-risk hematological malignancy were randomized in this study. One hundred and twelve patients received 6 mg/kg ATG, whereas the remaining patients received 10 mg/kg ATG. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.